Jade Biosciences (JBIO) Other Accumulated Expenses (2020 - 2025)

Jade Biosciences (JBIO) has 6 years of Other Accumulated Expenses data on file, last reported at $429000.0 in Q1 2025.

• For the quarter ending Q1 2025, Other Accumulated Expenses fell 36.35% year-over-year to $429000.0; the trailing twelve-month figure through Mar 2025 stood at $429000.0 (down 36.35% YoY), and the FY2024 full-year result was $319000.0, down 70.73% from the prior year.
• Other Accumulated Expenses for Q1 2025 stood at $429000.0, up from $319000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $1.1 million in Q4 2023 and bottomed at $120000.0 in Q2 2021.
• The 5-year median for Other Accumulated Expenses is $305500.0 (2024), against an average of $388500.0.
• The widest annual swing landed in 2021, when Other Accumulated Expenses jumped 694.44%; it then tumbled 70.73% in 2024.
• A 5-year view of Other Accumulated Expenses shows it stood at $143000.0 in 2021, then soared by 165.73% to $380000.0 in 2022, then soared by 186.84% to $1.1 million in 2023, then sank by 70.73% to $319000.0 in 2024, then jumped by 34.48% to $429000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $429000.0 (Q1 2025), $319000.0 (Q4 2024), and $292000.0 (Q3 2024), per Business Quant data.

Peer Comparison